The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Acute effects of nitric oxide on left ventricular relaxation and diastolic distensibility in humans. Assessment by bicoronary sodium nitroprusside infusion.
Abstract
BACKGROUND: In isolated mammalian cardiomyocytes, papillary muscle preparations, and ejecting hearts, nitric oxide (NO) or other cyclic GMP-elevating interventions increase diastolic cell length and reduce peak contractile performance by hastening onset of myocardial relaxation. In the present study, the effect of NO on left ventricular (LV) relaxation and diastolic distensibility was investigated in humans. METHODS AND RESULTS: The NO donor substance sodium nitroprusside was infused during cardiac catheterization in the global coronary bed of the LV of patients (n = 13) investigated for chest pain who were without evidence of obstructive coronary artery or other cardiac disease. Sodium nitroprusside was infused intracoronarily at a dosage (< or = 4 micrograms/min) that was previously shown to be devoid of systemic effects when infused into the brachial artery to investigate the reactivity of the forearm vascular bed. The effect of this global intracoronary infusion of the NO donor sodium nitroprusside was assessed by sequential LV angiograms and tip-micromanometer pressure recordings. During global intracoronary nitroprusside infusion, there was a decrease in heart rate from 78 +/- 11 to 76 +/- 12 beats per minute (P < .05), in LV peak systolic pressure from 161 +/- 18 to 146 +/- 18 mm Hg (P < .001), and in time to onset of LV relaxation (interval from Q wave on the ECG to LV dP/dtmin) from 432 +/- 36 to 419 +/- 36 milliseconds (P < .01). In 7 patients in whom adequate sequential LV angiograms could be obtained, LV end-diastolic volume increased from 158 +/- 34 to 165 +/- 40 mL (P < .05), whereas LV end-diastolic pressure fell from 18 +/- 5 to 12 +/- 3 mm Hg (P < .02), and in 5 of these 7 patients, a downward shift of the diastolic LV pressure-volume relation was observed. In 5 patients, a right atrial infusion of sodium nitroprusside was performed either before (n = 2) or after the global intracoronary infusion. The decrease in LV peak systolic pressure observed during right atrial infusion was significantly smaller (P < .01) than during global intracoronary infusion. CONCLUSIONS: The present study reveals reduced LV pressure development, an LV relaxation-hastening effect, and improved LV diastolic distensibility during global intracoronary infusion of the NO donor substance sodium nitroprusside. These effects appeared to be unrelated to systemic vasodilation or to pericardial constraint and could be explained by a direct myocardial effect of NO, probably through activation of guanylyl cyclase to increase cyclic GMP or through modification of other cellular proteins.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nitric oxide: physiology, pathophysiology, and pharmacology.
Moncada, S., Palmer, R. M., & Higgs, E. A. (1991) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06663-3 · Cited by 15,525
Furchgott, R. F., & Zawadzki, J. V. (1980) · Nature · doi:10.1038/288373a0 · Cited by 12,064
Biochemistry of nitric oxide and its redox-activated forms
Stamler, J. S., Singel, D. J., & Loscalzo, J. (1992) · Science · doi:10.1126/science.1281928 · Cited by 2,744
Abnormal Endothelium-Dependent Vascular Relaxation in Patients with Essential Hypertension
Panza, J. A., Quyyumi, A. A., Brush, J. E., & Epstein, S. E. (1990) · New England Journal of Medicine · doi:10.1056/nejm199007053230105 · Cited by 2,367
Negative Inotropic Effects of Cytokines on the Heart Mediated by Nitric Oxide
Finkel, M. S., Oddis, C. V., Jacob, T. D., Watkins, S. C., Hattler, B. G., & Simmons, R. L. (1992) · Science · doi:10.1126/science.1631560 · Cited by 1,628
Flow-induced release of endothelium-derived relaxing factor
Rubanyi, G. M., Romero, J. C., & Vanhoutte, P. M. (1986) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1986.250.6.h1145 · Cited by 1,366
Crucial role of endothelium in the vasodilator response to increased flow in vivo.
Pohl, U., Holtz, J., Busse, R., & Bassenge, E. (1986) · Hypertension · doi:10.1161/01.hyp.8.1.37 · Cited by 983
Left ventricular remodeling after myocardial infarction: a corollary to infarct expansion.
McKay, R. G., Pfeffer, M. A., Pasternak, R. C., Markis, J. E., Come, P. C., Nakao, S., Alderman, J. D., Ferguson, J. J., Safian, R. D., & Grossman, W. (1986) · Circulation · doi:10.1161/01.cir.74.4.693 · Cited by 731
Panza, J. A., Casino, P. R., Kilcoyne, C. M., & Quyyumi, A. A. (1993) · Circulation · doi:10.1161/01.cir.87.5.1468 · Cited by 707
Control of cardiac muscle cell function by an endogenous nitric oxide signaling system.
Balligand, J. L., Kelly, R. A., Marsden, P. A., Smith, T. W., & Michel, T. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.1.347 · Cited by 658
Cited by
Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment
Borlaug, B. A., & Paulus, W. J. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehq426 · Cited by 1,093
Self-citationNitric Oxide and Cardiac Function
Kelly, R. A., Balligand, J.-L., & Smith, T. W. (1996) · Circulation Research · doi:10.1161/01.res.79.3.363 · Cited by 711
Mechanisms of sepsis-induced cardiac dysfunction
Rudiger, A., & Singer, M. (2007) · Critical Care Medicine · doi:10.1097/01.ccm.0000266683.64081.02 · Cited by 704
Brutsaert, D. L. (2003) · Physiological Reviews · doi:10.1152/physrev.00017.2002 · Cited by 697
Adrenergic and Muscarinic Receptors in the Human Heart
Brodde, O.-E., & Michel, M. C. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01425-x · Cited by 673
Low Myocardial Protein Kinase G Activity in Heart Failure With Preserved Ejection Fraction
van Heerebeek, L., Hamdani, N., Falcão-Pires, I., Leite-Moreira, A. F., Begieneman, M. P. V., Bronzwaer, J. G. F., van der Velden, J., Stienen, G. J. M., Laarman, G. J., Somsen, A., et al. (2012) · Circulation · doi:10.1161/circulationaha.111.076075 · Cited by 525
Self-citationBalligand, J.-L., Feron, O., & Dessy, C. (2009) · Physiological Reviews · doi:10.1152/physrev.00042.2007 · Cited by 477
Krüger, M., Kötter, S., Grützner, A., Lang, P., Andresen, C., Redfield, M. M., Butt, E., dos Remedios, C. G., & Linke, W. A. (2009) · Circulation Research · doi:10.1161/circresaha.108.184408 · Cited by 407
Regulation of cardiac contractile function by troponin I phosphorylation
LAYLAND, J., SOLARO, R., & SHAH, A. (2005) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.12.022 · Cited by 385
Self-citationGuazzi, M., Vicenzi, M., Arena, R., & Guazzi, M. D. (2011) · Circulation: Heart Failure · doi:10.1161/circheartfailure.110.944694 · Cited by 382
Effects of Vasodilation in Heart Failure With Preserved or Reduced Ejection Fraction
Schwartzenberg, S., Redfield, M. M., From, A. M., Sorajja, P., Nishimura, R. A., & Borlaug, B. A. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.09.062 · Cited by 331
Recchia, F. A., McConnell, P. I., Bernstein, R. D., Vogel, T. R., Xu, X., & Hintze, T. H. (1998) · Circulation Research · doi:10.1161/01.res.83.10.969 · Cited by 302
Paolocci, N., Saavedra, W. F., Miranda, K. M., Martignani, C., Isoda, T., Hare, J. M., Espey, M. G., Fukuto, J. M., Feelisch, M., Wink, D. A., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.181191198 · Cited by 298
Paracrine and autocrine effects of nitric oxide on myocardial function
Shah, A. (2000) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(99)00072-8 · Cited by 293
Self-citationMyocardial Contractile Response to Nitric Oxide and cGMP
Mohan, P., Brutsaert, D. L., Paulus, W. J., & Sys, S. U. (1996) · Circulation · doi:10.1161/01.cir.93.6.1223 · Cited by 281
Self-citationKojda, G., Kottenberg, K., Nix, P., Schlüter, K. D., Piper, H. M., & Noack, E. (1996) · Circulation Research · doi:10.1161/01.res.78.1.91 · Cited by 258
Cardiovascular effects of inhaled nitric oxide in patients with left ventricular dysfunction.
Loh, E., Stamler, J. S., Hare, J. M., Loscalzo, J., & Colucci, W. S. (1994) · Circulation · doi:10.1161/01.cir.90.6.2780 · Cited by 258
Donzelli, S., Espey, M. G., Flores-Santana, W., Switzer, C. H., Yeh, G. C., Huang, J., Stuehr, D. J., King, S. B., Miranda, K. M., & Wink, D. A. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.04.036 · Cited by 91
Handa, H., Brisbois, E. J., Major, T. C., Refahiyat, L., Amoako, K. A., Annich, G. M., Bartlett, R. H., & Meyerhoff, M. E. (2013) · Journal of Materials Chemistry B · doi:10.1039/c3tb20277a · Cited by 64
L‐Arginine reduces heart rate and improves hemodynamics in severe congestive heart failure
Bocchi, E. A., De Moraes, A. V., Esteves‐Filho, A., Bacal, F., Auler, J. O., Carmona, M. J., Bellotti, G., & Ramires, A. F. (2000) · Clinical Cardiology · doi:10.1002/clc.4960230314 · Cited by 45
Plasma nitrate plus nitrite changes during continuous intravenous infusion interleukin 2
Citterio, G., Pellegatta, F., Lucca, G., Fragasso, G., Scaglietti, U., Pini, D., Fortis, C., Tresoldi, M., & Rugarli, C. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.533 · Cited by 18
Hemodynamic characteristics of patients with diastolic heart failure and hypertension.
FUJIMOTO, N., ONISHI, K., DOHI, K., TANABE, M., KURITA, T., TAKAMURA, T., YAMADA, N., NOBORI, T., & ITO, M. (2008) · Hypertension Research · doi:10.1291/hypres.31.1727 · Cited by 11
Metadata
- Authors
- Paulus, W. J., Vantrimpont, P. J., & Shah, A. M.
- Venue
- Circulation
- Published
- 1994-05
- Volume
- 89
- Issue
- 5
- Pages
- 2070-2078
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2060411128
- Cited by
- 370
- References
- 36
- FWCI
- 23.07
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.